Effects of preoperative 5-aminolevulinic acid administration on postoperative liver enzymes after brain tumor surgery in patients with elevated preoperative liver enzymes
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 72, 304-309
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 5‐ALA in the management of malignant gliomaLasers in Surgery and Medicine, 2018
- Evaluation of the risk of liver damage from the use of 5-aminolevulinic acid for intra-operative identification and resection in patients with malignant gliomasActa Neurochirurgica, 2016
- Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort StudyPLOS ONE, 2016
- Protoporphyrin IX: the Good, the Bad, and the UglyThe Journal of Pharmacology and Experimental Therapeutics, 2016
- Neurosurgical oncology: advances in operative technologies and adjunctsJournal of Neuro-Oncology, 2014
- Risk factors for developing oral 5-aminolevulenic acid-induced side effects in patients undergoing fluorescence guided resectionPhotodiagnosis and Photodynamic Therapy, 2013
- Hepatic safety of antibiotics used in primary careJournal of Antimicrobial Chemotherapy, 2011
- GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOMENeurosurgery, 2008
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Liver enzyme alteration: a guide for cliniciansCanadian Medical Association Journal, 2005